Table 2 Prevalence of pHR/HR and low risk HPV infection and other sexually transmitted infections
Type of infection | N | Percentage (95 % CI) |
|---|---|---|
HR HPV: | ||
 HPV 16 | 25 | 33.8 % (22.8–44.8) |
 HPV 18 | 13 | 17.6 % (8.7–26.4) |
 HPV 31 | 11 | 14.9 % (6.6–23.2) |
 HPV 33 | 12 | 16.2 % (7.6–24.8) |
 HPV 35 | 13 | 17.6 % (8.7–26.4) |
 HPV 45 | 3 | 4.1 % (0.5–8.7) |
 HPV 39 | 8 | 10.8 % (3.6–18.1) |
 HPV 51 | 11 | 14.9 % (6.6–23.2) |
 HPV 52 | 15 | 20.3 % (10.9–29.6) |
 HPV 53 | 18 | 24.3 % (14.3–34.4) |
 HPV 56 | 15 | 20.3 % (10.9–29.6) |
 HPV 58 | 13 | 17.6 % (8.7–26.4) |
 HPV 66 | 11 | 14.9 % (6.6–23.2) |
 HPV 68 | 4 | 5.4 % (0.1–10.7) |
 Multiple HR HPV | 48 | 64.9 % (53.7–76.0) |
 Women on HAART | 60 | 82.0 (80.0–90.2) |
LR HPV: | ||
 HPV 6 | 4 | 5.4 % (4.4–6.4) |
 HPV 67 | 0 | 0 |
 No HPV infection: | 6 | 8.1 % (3.0–16.8) |
STIs: | ||
 BV | 46 | 62.2 % (50.9–73.5) |
 Genital ulcer | 12 | 16.2 % (7.6–24.8) |
 Genital warts | 8 | 10.8 % (3.6–18.1) |
 Trichomonas vaginalis | 1 | 1.4 % (0.1–4.0) |
 Cervicitis | 11 | 14.9 % (6.6–23.2) |
 STI prevalence | 51 | 68.9 % (58.1–79.7) |
 More than one STI | 8 | 10.7 % (3.5–17.8) |